Total Enterprise Value: Sionna Therapeutics Inc (SION)

Graphic logo of Sionna Corp (SION)

Sionna Therapeutics Inc (SION) specializes in developing advanced treatments for cystic fibrosis. The company utilizes nitrogen-based cryogenic systems for the transport of biomaterials. The price indicator on the GURU.Markets chart is -27.99, confirming available resources and cost control. The business model relies on the clinical trial progression of unique molecules, which determines the overall success of this biotech's development strategy.

Sionna Corp (SION) - Enterprise Value from 11/23/2025 to 10/31/2026

Sionna Therapeutics Inc (SION) - metric breakdowns and financial figures

- stock value and consensus price forecast:
Market Chart Sionna Therapeutics, Inc.|SION - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Sionna Therapeutics|SION - Total Company Value
- book capitalization data:
Equity per Share Sionna Therapeutics|SION - Book Capitalization|Capitalization to Book Value Ratio sionnatx.com|SION - Aggregate Company Assets
- debt level and financial liquidity data:
Debt to Equity Ratio Sionna Therapeutics Inc|SION - Long-Term Debt to Capital|Short-Term Debt to Capital sionnatx.com|SION - Company Debts|Debts to Net Assets Sionna Therapeutics|SION - Company Long-Term Debts|Short-Term Debt Volume Sionna Therapeutics|Immediate Liquidity sionnatx.com
- earnings and valuation multiples indicators:
SION - Company Net Income
Analysis of all company metrics:SION Sionna Therapeutics, Inc.
Flagship merchandise of Sionna Therapeutics Inc

The indicator's formula is highly sensitive to the balance between borrowed funds and liquidity. This metric determines the total cost of business acquisition by summing market capitalization and debt, minus cash reserves. For Sionna Therapeutics Inc (SION), this calculation is critical due to geopolitical risks affecting supply chain costs and patent protection. By analyzing the estimated enterprise value on GURU.Markets, an investor assesses the asset's real price. The dynamics of this line help avoid overpaying during a purchase.

Who Sionna Therapeutics Inc competes with

Company Buyout Price Tempus AI (TEM)|QGEN - Total Company Value|Total Enterprise Value Isis Pharmaceuticals|Repligen Corporation (RGEN) - Total Company Value|Business Value RNA|CRSP (CRISPR Therapeutics) - Enterprise Value|Business Value WGS (GeneDx Holdings)|Total Company Value Ultragenyx Pharma (RARE)|Beam Tx - Business Value|Enterprise Value SRPT (Sarepta Therapeutics, Inc.)|Enterprise Value twistbioscience.com TWST|TXG - Total Company Value|Company Buyout Price Intellia Therapeutics Inc NTLA|STOK: Enterprise Value|BLFS - Company Buyout Price|Total Company Value Wave Life Sciences|Total Enterprise Value mazetx.com MAZE|Total Company Value Prime Medicine (PRME)|Taysha Gene Therapies Inc - Business Value|Total Company Value uniQure Corp QURE|MGTX: Business Value|REGENXBIO Inc. - Enterprise Value|SLDB - Enterprise Value|OCGN (Ocugen) - Real Price to Acquire Entire Company|Pacific Biosciences of California, Inc. - Value Adjusted for Debt and Cash|Real Price to Acquire Entire Company BNTC|DSGN (Design Corp) - Aggregate Business Value|Enterprise Value RCKT|FDMT (4dmoleculartherapeutics.com) - Value Adjusted for Debt and Cash|Enterprise Value LXEO (Lexeo Therapeutics, Inc.)|Korro Bio Inc. (KRRO) - Total Enterprise Value|EDIT - Total Company Value|Value Adjusted for Debt and Cash SLN (Silence Therapeutics Corp)|PRQR: Enterprise Value|Codexis (CDXS) - Enterprise Value|Total Company Value Sangamo Therapeutics, Inc.|Nautilus Biotechnology Inc - Full Business Value|Enterprise Value MGX|DTIL - Total Enterprise Value|Generation Bio - Real Price to Acquire Entire Company|Enterprise Value boundlessbio.com BOLD|XCUR: Real Price to Acquire Entire Company|Imunon, Inc. - Aggregate Business Value|PHIO: Enterprise Value|MBIO - Company Buyout Price|RNAZ (TransCode Therapeutics Inc.) - Enterprise Value|Real Price to Acquire Entire Company Bionano (BNGO)|Total Company Value Applied DNA Sciences, Inc. (APDN)|Company Buyout Price bluebird bio Inc.|ImmunoPrecise Antibodies Ltd. - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash OMGA|Singular Genomics Systems - Enterprise Value|Company Buyout Price regulusrx.com RGLS|Syros Pharmaceuticals, Inc. (SYRS) - Total Company Value|Business Value TBIO|TCON (TRACON) - Enterprise Value|Real Price to Acquire Entire Company Unity Biotechnology, Inc (UBX)